Here is some other vaccine news of note for the week.

China has withheld shipments of the H7N9 strain to the U.S. for research, according to The New York Times.

CSL's flu vaccine unit Seqirus posted $1.09 billion in sales during its 2018 fiscal year and turned in its first-ever profit.

Here is some other vaccine news of note for the week.

Profectus’ Lassa candidate is based on its VesiculoVax vaccine delivery platform, which uses vesicular stomatitis virus as vector.

Sanofi might need to work out some extraordinary measures to ensure flu vaccine supplies to the U.K. in case of a no-deal Brexit.

Bi Jingquan, who headed CFDA for three years, was asked to resign from his current position at the all-powerful State Administration for Market Regulation.

Here is some other vaccine news of note for the week.